-
Something wrong with this record ?
BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia
M. Helan, B. Aravamudan, WR. Hartman, MA. Thompson, BD. Johnson, CM. Pabelick, YS. Prakash,
Language English Country England, Great Britain
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- MeSH
- Arginase metabolism MeSH
- Pulmonary Artery pathology MeSH
- Endothelium, Vascular pathology MeSH
- Endothelial Cells metabolism secretion MeSH
- Gene Expression MeSH
- Hypoxia-Inducible Factor 1 metabolism MeSH
- Cell Hypoxia MeSH
- Hypoxia blood MeSH
- Cells, Cultured MeSH
- Humans MeSH
- RNA, Messenger genetics metabolism MeSH
- Brain-Derived Neurotrophic Factor blood genetics secretion MeSH
- Nitric Oxide metabolism MeSH
- Protein Kinases metabolism MeSH
- Signal Transduction MeSH
- Nitric Oxide Synthase Type II metabolism MeSH
- Nitric Oxide Synthase Type III metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
Within human pulmonary artery, neurotrophin growth factors [NTs; e.g. brain-derived neurotrophic factor (BDNF)] and their high-affinity receptors (tropomyosin-related kinase; Trk) and low-affinity receptors p75 neurotrophin receptor (p75NTR) have been reported, but their functional role is incompletely understood. We tested the hypothesis that BDNF is produced by human pulmonary artery endothelial cells (PAECs). In the context of hypoxia as a risk factor for pulmonary hypertension, we examined the effect of hypoxia on BDNF secretion and consequent autocrine effects on pulmonary endothelium. Initial ELISA analysis of circulating BDNF in 30 healthy human volunteers showed that 72 h exposure to high altitude (~11,000 ft, alveolar PO2 = 100 mmHg) results in higher BDNF compared to samples taken at sea level. Separately, in human PAECs exposed for 24h to normoxia vs. hypoxia (1-3% O2), ELISA of extracellular media showed increased BDNF levels. Furthermore, quantitative PCR of PAECs showed 3-fold enhancement of BDNF gene transcription with hypoxia. In PAECs, BDNF induced NO production (measured using an NO-sensitive fluorescent dye DAF2-DA) that was significantly higher under hypoxic conditions, an effect also noted with the TrkB agonist 7,8-DHF. Importantly, hypoxia-induced NO was blunted by neutralization of secreted BDNF using the chimeric TrkB-Fc. Both hypoxia and BDNF increased iNOS (but not eNOS) mRNA expression. In accordance, BDNF enhancement of NO in hypoxia was not blunted by 50 nM L-NAME (eNOS inhibition) but substantially lower with 100 μM L-NAME (eNOS and iNOS inhibition). Hypoxia and BDNF also induced expression of hypoxia inducible factor 1 alpha (HIF-1α), a subunit of the transcription factor HIF-1, and pharmacological inhibition of HIF-1 diminished hypoxia effects on BDNF expression and secretion, and NO production. These results indicate that human PAECs express and secrete BDNF in response to hypoxia via a HIF-1-regulated pathway.
Department of Anesthesiology Mayo Clinic Rochester USA
Department of Medicine Division of Cardiovascular Diseases Mayo Clinic Rochester USA
Department of Physiology and Biomedical Engineering Mayo Clinic Rochester USA
ICRC International Clinical Research Center Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008373
- 003
- CZ-PrNML
- 005
- 20150327115222.0
- 007
- ta
- 008
- 150306s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.yjmcc.2014.01.006 $2 doi
- 035 __
- $a (PubMed)24462831
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Helan, Martin $u Department of Anesthesiology, Mayo Clinic, Rochester, USA; ICRC, International Clinical Research Center, Brno, Czech Republic; Department of Anesthesiology and Intensive Care, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 245 10
- $a BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia / $c M. Helan, B. Aravamudan, WR. Hartman, MA. Thompson, BD. Johnson, CM. Pabelick, YS. Prakash,
- 520 9_
- $a Within human pulmonary artery, neurotrophin growth factors [NTs; e.g. brain-derived neurotrophic factor (BDNF)] and their high-affinity receptors (tropomyosin-related kinase; Trk) and low-affinity receptors p75 neurotrophin receptor (p75NTR) have been reported, but their functional role is incompletely understood. We tested the hypothesis that BDNF is produced by human pulmonary artery endothelial cells (PAECs). In the context of hypoxia as a risk factor for pulmonary hypertension, we examined the effect of hypoxia on BDNF secretion and consequent autocrine effects on pulmonary endothelium. Initial ELISA analysis of circulating BDNF in 30 healthy human volunteers showed that 72 h exposure to high altitude (~11,000 ft, alveolar PO2 = 100 mmHg) results in higher BDNF compared to samples taken at sea level. Separately, in human PAECs exposed for 24h to normoxia vs. hypoxia (1-3% O2), ELISA of extracellular media showed increased BDNF levels. Furthermore, quantitative PCR of PAECs showed 3-fold enhancement of BDNF gene transcription with hypoxia. In PAECs, BDNF induced NO production (measured using an NO-sensitive fluorescent dye DAF2-DA) that was significantly higher under hypoxic conditions, an effect also noted with the TrkB agonist 7,8-DHF. Importantly, hypoxia-induced NO was blunted by neutralization of secreted BDNF using the chimeric TrkB-Fc. Both hypoxia and BDNF increased iNOS (but not eNOS) mRNA expression. In accordance, BDNF enhancement of NO in hypoxia was not blunted by 50 nM L-NAME (eNOS inhibition) but substantially lower with 100 μM L-NAME (eNOS and iNOS inhibition). Hypoxia and BDNF also induced expression of hypoxia inducible factor 1 alpha (HIF-1α), a subunit of the transcription factor HIF-1, and pharmacological inhibition of HIF-1 diminished hypoxia effects on BDNF expression and secretion, and NO production. These results indicate that human PAECs express and secrete BDNF in response to hypoxia via a HIF-1-regulated pathway.
- 650 _2
- $a hypoxie $x krev $7 D000860
- 650 _2
- $a arginasa $x metabolismus $7 D001119
- 650 _2
- $a mozkový neurotrofický faktor $x krev $x genetika $x sekrece $7 D019208
- 650 _2
- $a hypoxie buňky $7 D015687
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a endoteliální buňky $x metabolismus $x sekrece $7 D042783
- 650 _2
- $a cévní endotel $x patologie $7 D004730
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a faktor 1 indukovatelný hypoxií $x metabolismus $7 D051793
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a synthasa oxidu dusnatého, typ II $x metabolismus $7 D052247
- 650 _2
- $a synthasa oxidu dusnatého, typ III $x metabolismus $7 D052250
- 650 _2
- $a proteinkinasy $x metabolismus $7 D011494
- 650 _2
- $a arteria pulmonalis $x patologie $7 D011651
- 650 _2
- $a messenger RNA $x genetika $x metabolismus $7 D012333
- 650 _2
- $a signální transdukce $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Aravamudan, Bharathi $u Department of Anesthesiology, Mayo Clinic, Rochester, USA. $7 gn_A_00008046
- 700 1_
- $a Hartman, William R $u Department of Anesthesiology, Mayo Clinic, Rochester, USA; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, USA.
- 700 1_
- $a Thompson, Michael A $u Department of Anesthesiology, Mayo Clinic, Rochester, USA.
- 700 1_
- $a Johnson, Bruce D $u Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, USA.
- 700 1_
- $a Pabelick, Christina M $u Department of Anesthesiology, Mayo Clinic, Rochester, USA; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, USA.
- 700 1_
- $a Prakash, Y S $u Department of Anesthesiology, Mayo Clinic, Rochester, USA; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, USA. Electronic address: Prakash.ys@mayo.edu.
- 773 0_
- $w MED00002807 $t Journal of molecular and cellular cardiology $x 1095-8584 $g Roč. 68, č. - (2014), s. 89-97
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24462831 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150327115544 $b ABA008
- 999 __
- $a ok $b bmc $g 1065646 $s 891173
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 68 $c - $d 89-97 $i 1095-8584 $m Journal of Molecular and Cellular Cardiology $n J Mol Cell Cardiol $x MED00002807
- LZP __
- $a Pubmed-20150306